📰 Abt News
Page 85 - Abt News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Abt. Real-time updates on events, politics, business and more.
October 11, 2023
IFM Investors Pty Ltd boosted its stake in Abbott Laboratories (NYSE:ABT – Free Report) by 6.1% in the 2nd quarter, Holdings Channel.com reports. The firm owned 340,147 shares of the healthcare product maker’s stock after acquiring an additional 19,582 shares during the quarter. IFM Investors Pty Ltd’s holdings in Abbott Laboratories were worth $37,083,000 at […]
October 11, 2023
Health-care companies fell as traders digested the mixed implications of blockbuster obesity drugs. Shares of Danish obesity-drug maker Novo Nordisk rallied...
October 10, 2023
Everett Harris & Co. CA cut its position in shares of Abbott Laboratories (NYSE:ABT – Free Report) by 0.2% during the 2nd quarter, according to the company in its most recent Form 13F filing with the SEC. The fund owned 1,555,501 shares of the healthcare product maker’s stock after selling 2,664 shares during the quarter. […]
October 10, 2023
Capital Advisors Ltd. LLC grew its stake in shares of Abbott Laboratories (NYSE:ABT – Free Report) by 84.0% during the 2nd quarter, Holdings Channel.com reports. The firm owned 3,074 shares of the healthcare product maker’s stock after acquiring an additional 1,403 shares during the period. Capital Advisors Ltd. LLC’s holdings in Abbott Laboratories were worth […]
October 10, 2023
Kesler Norman & Wride LLC increased its stake in Abbott Laboratories (NYSE:ABT – Free Report) by 2.9% in the second quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 53,882 shares of the healthcare product maker’s stock after purchasing an additional 1,510 shares during the […]
October 10, 2023
Capital Advisors Ltd. LLC boosted its stake in shares of Abbott Laboratories (NYSE:ABT – Free Report) by 84.0% in the 2nd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 3,074 shares of the healthcare product maker’s stock after acquiring an additional 1,403 shares […]
October 10, 2023
Pallas Capital Advisors LLC decreased its holdings in shares of Abbott Laboratories (NYSE:ABT – Free Report) by 3.7% during the 2nd quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 4,214 shares of the healthcare product maker’s stock after selling 161 shares during the quarter. Pallas […]
October 10, 2023
Moody Lynn & Lieberson LLC boosted its position in shares of Abbott Laboratories (NYSE:ABT – Free Report) by 2.0% during the 2nd quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 209,471 shares of the healthcare product maker’s stock after purchasing an additional 4,050 shares during the […]
October 10, 2023
Grove Bank & Trust raised its holdings in Abbott Laboratories (NYSE:ABT – Free Report) by 2.3% in the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 29,465 shares of the healthcare product maker’s stock after acquiring an additional 663 shares during the quarter. Grove Bank […]
October 10, 2023
Fulcrum Capital LLC lowered its holdings in shares of Abbott Laboratories (NYSE:ABT – Free Report) by 4.1% in the second quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 54,522 shares of the healthcare product maker’s stock after selling 2,315 shares during the period. Abbott Laboratories comprises about 1.6% […]